North Macedonia Reports First Cases of Mpox
North Macedonia reports its first cases of mpox, a viral disease related to smallpox, confirming the importance of ongoing surveillance and public health preparedness.
In a recent development, North Macedonia has documented its first-ever cases of mpox, also known as monkeypox, a viral disease related to smallpox. On May 23, 2025, the country's health authorities confirmed that two male residents of Skopje, aged 40 and 44, tested positive for the virus. Interestingly, both individuals reported no recent travel abroad or connection to each other, indicating potential local transmission. The confirmation came after three different laboratory tests verified the cases.
The Institute for Public Health's director, Marija Andonovska, stated during a press conference that these are the first recorded instances of mpox in North Macedonia. Deputy Health Minister Jovica Andovski reassured the public that the disease is manageable, as there is an established protocol for treatment.
Authorities promptly responded by contacting relevant health institutions and convening a meeting to determine subsequent steps. Mpox, caused by a virus belonging to the same family as smallpox, manifests initially with high fever followed by skin lesions. Historically confined to certain African countries since its identification in the Democratic Republic of Congo in 1970, mpox has gained global attention after spreading more widely from 2022.
The World Health Organization raised its alert level for mpox in 2024, emphasizing the importance of surveillance and preparedness. North Macedonia's first cases highlight the ongoing need for vigilance and public health measures to prevent further spread of the virus.
For more details, visit: https://medicalxpress.com/news/2025-05-north-macedonia-cases-mpox.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rising Trends in Preterm Births in the United States from 2014 to 2023
A new study reports a significant increase in preterm and early-term births in the U.S. from 2014 to 2023, highlighting shifts in obstetric practices and implications for infant health.
Potential of Methylene Blue to Shield Lungs During Major Heart Surgeries: New Research
A new study suggests that methylene blue may protect lungs from damage during complex heart surgeries involving circulatory arrest, offering a promising low-cost intervention to prevent acute lung injury.
Cost Comparison: Multitarget Stool DNA Tests vs. FIT for Early Detection of Colorectal Cancer
A new study compares the costs of multitarget stool DNA tests and FIT for early detection of colorectal cancer, revealing higher expenses associated with DNA-based methods despite their increased sensitivity. The findings highlight the importance of cost-effectiveness in colorectal cancer screening strategies.